Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.
Post : Formulation Analytical Research & Development
Department of Pharmaceuticals has approved four medical devices park across India and around Rs. 25 crores finacial assiatance to each, informed by Sh Ashwini Kumar Choubey, Minister of State (Health and Family Welfare).
Indoco Remedies announced that its sterile manufacturing facility (Plant II) at Verna, Goa, has received EU GMP certification from the UK Health Regulator.

This is an outcome from the last successful inspection conducted by UK MHRA from 16th to 20th September 2019.
Biocon Ltd an innovation-led global biopharmaceuticals company and Equillium Inc, a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, announced that they have expanded their collaboration and license agreement for itolizumab to grant Equillium exclusive rights for developing and commercializing itolizumab in Australia and New Zealand.

Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the U.S. and Canada markets, in May 2017.
A treatment for neurological disorder, Huntington's disease, could be in the offing. A group of researchers from the Indian Institute of Technology-Indore have identified three chemical molecules that could potentiually be used to arrest its progression.
Under Ayushman Bharat, Government has done addition to the primary health team at the Sub Health Centres and Health & Wellness Centres (HWC), would be the Mid-level Health Provider (MLHP) who would be a Community Health Officer. And National Health Mission (NHM) confirmed that Pharmacists are not eligible for same.
A common concern with oral vitamin B12 therapy is absorption especially in people suffering from anemia and gastrointestinal diseases. Researchers at the Council of Scientific and Industrial Research-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) have identified a plant extract that has shown potential in enhancing absorption of vitamin B12 through in vitro and in vivo bioassays.